18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases

Molecular Imaging

Volumn 11, Issue 2, 2012, Pages 148-154

  De Jong, Gabie M ^a   Hendriks, Thijs ^a   Bleichrodt, Robert P ^a   Dekker, Helena M ^a   Mus, Roel D M ^a   Gotthardt, Martin ^a   Visser, Eric P ^a   Oyen, Wim J G ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTED TOMOGRAPHY; DETECTABILITY; IMAGING MODALITY; LIVER METASTASIS; LIVER TUMORS; TIME POINTS; TUMOR CELLS; TUMOR INDUCTION;

IMAGE SEGMENTATION; MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RATS; TUMORS;

COMPUTERIZED TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ANIMAL; ARTICLE; ARTIFACT; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; IMAGE PROCESSING; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RAT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ANIMALS; ARTIFACTS; COLORECTAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; RATS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84860752885     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00035     Document Type: Article

References (18)

1. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18, doi:10.1097/00000658- 199909000-00004. (Pubitemid 30191861)
2. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-33, doi:10.1016/S0959- 8049(02)00059-X. (Pubitemid 34442330)
3. Harry VN, Semple SI, Parkin DE, Gilbert FJ. Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol 2010;11:92-102, doi:10.1016/S1470-2045(09)70190-1.
4. de Geus-Oei LF, Vriens D, van Laarhoven HW, et al. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 2009;50 Suppl 1:43S-54S, doi:10.2967/jnumed.108. 057224.
5. Vriens D, van Laarhoven HW, van Asten JJ, et al. Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd- DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate. J NuclMed 2009;50:1777-84, doi:10.2967/jnumed.109.064790.
6. Tol J, Koopman M, Cats A, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009; 360:563-72, doi:10.1056/NEJMoa0808268.
7. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT,MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005;237:123-31, doi:10.1148/radiol.2371042060. (Pubitemid 41346155)
8. Zedeck MS. A model system for studies of colon carcinogenesis: tumor induction by a single injection of methylazoxymethanol acetate. J Natl Cancer Inst 1974;53:1419-21.
9. Koppe MJ, Hendriks T, Boerman OC, et al. Radioimmunotherapy is an effective adjuvant treatment modality after cytoreductive surgery of peritoneal carcinomatosis of colonic origin. J Nucl Med 2006;47:1867-74. (Pubitemid 47545010)
10. de Jong GM, Hendriks T, Eek A, et al. Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin. Ann Surg Oncol 2009;16:2065-73, doi:10.1245/ s10434-009-0477-6.
11. Visser EP, Disselhorst JA, Brom M, et al. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 2009;50:139-47, doi:10.2967/jnumed.108.055152.
12. Gambarota G, Veltien A, van Laarhoven H, et al. Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T. MAGMA 2004;17:281-7, doi:10.1007/s10334-004- 0068-2. (Pubitemid 40362311)
13. Cohen J. Statistical power analysis for the behavioral sciences. New York: Lawrence Erlbaum; 1988.
14. Fueger BJ, Czernin J, Hildebrandt I, et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 2006;47:999-1006. (Pubitemid 46939953)
15. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PETMRI: a new approach for functional and morphological imaging. Nat Med 2008;14:459-65, doi:10.1038/nm1700. (Pubitemid 351499385)
16. Vogel WV, van Dalen JA, Wiering B, et al. Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging. J Nucl Med 2007;48:910-9, doi:10.2967/ jnumed.107.041517. (Pubitemid 46909919)
17. Wiering B, Vogel WV, Ruers TJ, Oyen WJ. Controversies in the management of colorectal liver metastases: role of PET and PET/ CT. Dig Surg 2008;25:413-20, doi:10.1159/000184732.
18. Boerman OC, Oyen WJ. Multimodality probes: amphibian cars for molecular imaging. J Nucl Med 2008;49:1213-4, doi:10.2967/ jnumed.108.052274.